Stryker wins deals for joint preservation, spine medical devices

Stryker Corp. (NYSE:SYK) inked new deals for its joint preservation arm and its interventional spine division this week.

The Kalamazoo, Mich.-based company added its inflatable vertebral augmentation system (iVAS) to its national agreement with supply contracting company Novation LLC.

The deal makes Stryker the single source for balloon-assisted spine augmentation for health care groups UHC, VHA Inc, and Provista LLC, according to the release.

The orthopedic giant also struck a deal to distribute its RegenKit-THT, designed to aid preparation of autologous platelet-rich plasma from a patient blood sample at the point of care, through RegenLab SA.

Stryker’s RegenKit-THT boasts the highest platelet recovery and viability, according to a company release.

“The RegenKit-THT system is the result of 10 years of scientific research in tissue regeneration and is designed to provide an autologous and physiological solution to promote a biological environment for regenerative cells enrichment. RegenLab is pleased to collaborate with Stryker, a leader in medical technologies and innovation, which will allow for the widespread distribution of our A-PRP technology,” saidAntoine Turzi, founder & CEO of RegenLab.